Compare with MALAR HOSP. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS vs FORTIS MALAR - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KRSNAA DIAGNOSTICS FORTIS MALAR KRSNAA DIAGNOSTICS/
FORTIS MALAR
 
P/E (TTM) x - -16.5 - View Chart
P/BV x 9.9 1.4 725.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 KRSNAA DIAGNOSTICS   FORTIS MALAR
EQUITY SHARE DATA
    KRSNAA DIAGNOSTICS
Mar-21
FORTIS MALAR
Mar-21
KRSNAA DIAGNOSTICS/
FORTIS MALAR
5-Yr Chart
Click to enlarge
High RsNA65 0.0%   
Low RsNA39 0.0%   
Sales per share (Unadj.) Rs998.836.9 2,703.2%  
Earnings per share (Unadj.) Rs284.5-4.2 -6,775.5%  
Cash flow per share (Unadj.) Rs342.12.7 12,804.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %NM0- 
Book value per share (Unadj.) Rs355.547.4 750.6%  
Shares outstanding (eoy) m6.5018.74 34.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x01.4 0.0%   
Avg P/E ratio x0-12.3 0.0%  
P/CF ratio (eoy) x019.3 0.0%  
Price / Book Value ratio x01.1 0.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m0968 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m296183 162.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,492692 937.6%  
Other income Rs m12283 148.3%   
Total revenues Rs m6,615775 853.6%   
Gross profit Rs m3,4665 67,694.3%  
Depreciation Rs m374129 290.8%   
Interest Rs m25972 360.3%   
Profit before tax Rs m2,955-113 -2,611.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,105-34 -3,210.1%   
Profit after tax Rs m1,849-79 -2,350.1%  
Gross profit margin %53.40.7 7,224.1%  
Effective tax rate %37.430.4 122.9%   
Net profit margin %28.5-11.4 -250.7%  
BALANCE SHEET DATA
Current assets Rs m2,481600 413.7%   
Current liabilities Rs m1,838247 744.7%   
Net working cap to sales %9.951.0 19.4%  
Current ratio x1.42.4 55.6%  
Inventory Days Days25168 14.8%  
Debtors Days Days41110 37.0%  
Net fixed assets Rs m3,5641,007 354.1%   
Share capital Rs m2,489188 1,326.9%   
"Free" reserves Rs m-178700 -25.5%   
Net worth Rs m2,310887 260.3%   
Long term debt Rs m1,6800-   
Total assets Rs m6,0451,606 376.3%  
Interest coverage x12.4-0.6 -2,168.6%   
Debt to equity ratio x0.70-  
Sales to assets ratio x1.10.4 249.1%   
Return on assets %34.9-0.4 -8,364.4%  
Return on equity %80.0-8.9 -902.7%  
Return on capital %80.5-4.6 -1,738.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m09 0.0%   
Fx outflow Rs m02 0.0%   
Net fx Rs m07 0.0%   
CASH FLOW
From Operations Rs m1,026-9 -11,883.9%  
From Investments Rs m-611-275 222.2%  
From Financial Activity Rs m308-72 -425.6%  
Net Cashflow Rs m723-356 -202.8%  

Share Holding

Indian Promoters % 27.4 62.7 43.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.2 0.1 51,657.1%  
FIIs % 6.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 37.3 194.7%  
Shareholders   75,554 9,422 801.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KRSNAA DIAGNOSTICS With:   FORTIS HEALTHCARE  INDRAPRASTHA MEDICAL  THYROCARE TECHNOLOGIES  DR. LAL PATHLABS  METROPOLIS HEALTHCARE  



Today's Market

4 Reasons Why Sensex Surged 1,016 Points Today(Closing)

Indian share markets continued their momentum and ended their day on a strong note today.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

6 Penny Stocks that Rallied 1,000%+ in One Year(Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KRSNAA DIAGNOSTICS SHARE PRICE


Dec 8, 2021 (Close)

TRACK KRSNAA DIAGNOSTICS

  • Track your investment in KRSNAA DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KRSNAA DIAGNOSTICS

KRSNAA DIAGNOSTICS - ASPIRA PATHLAB & DIAGNOSTICS COMPARISON

COMPARE KRSNAA DIAGNOSTICS WITH

MARKET STATS